Viewing Study NCT00068757

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 6:56 PM

Ignite Modification Date: 2026-02-19 @ 2:50 AM

Study NCT ID: NCT00068757

Status: COMPLETED

Last Update Posted: 2012-09-12

First Post: 2003-09-10

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module